UPDATE: FDA-Approved Product Further Expands Endo's Branded Pharmaceutical Men's Health Portfolio
November 24, 2014 at 07:02 AM EST
Endo International plc (NASDAQ: ENDP) (TSX: ENL), announced today the acquisition of rights to Natesto™ (testosterone nasal gel), the ...